IRIS
CASSANI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.146
AS - Asia 1.019
EU - Europa 690
SA - Sud America 160
AF - Africa 15
OC - Oceania 2
Totale 3.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.084
CN - Cina 390
SG - Singapore 316
RU - Federazione Russa 174
HK - Hong Kong 170
IE - Irlanda 149
BR - Brasile 132
DE - Germania 108
IT - Italia 78
FI - Finlandia 56
VN - Vietnam 55
GB - Regno Unito 35
CA - Canada 29
MX - Messico 24
BD - Bangladesh 16
IN - India 15
AR - Argentina 14
JP - Giappone 12
PL - Polonia 12
AT - Austria 11
FR - Francia 10
ES - Italia 8
IQ - Iraq 8
UA - Ucraina 8
SE - Svezia 7
BE - Belgio 6
MA - Marocco 6
PT - Portogallo 6
LT - Lituania 5
PH - Filippine 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
NL - Olanda 4
SA - Arabia Saudita 4
CL - Cile 3
CZ - Repubblica Ceca 3
TR - Turchia 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
ID - Indonesia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MN - Mongolia 2
PA - Panama 2
PY - Paraguay 2
TM - Turkmenistan 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
Totale 3.032
Salva come PNG Salva come JPEG
Città #
Hong Kong 170
Singapore 151
Dublin 148
Dallas 146
Chandler 124
Beijing 111
Ashburn 97
Boardman 56
New York 55
Los Angeles 53
Munich 51
Redondo Beach 47
Nanjing 42
Shanghai 40
Moscow 30
Jacksonville 29
Ho Chi Minh City 23
Turku 23
Princeton 22
Lawrence 21
Nanchang 21
Milan 19
Wilmington 19
Buffalo 18
Helsinki 18
Medford 18
Hanoi 15
Jiaxing 15
Nuremberg 15
Brooklyn 14
Toronto 13
Seattle 12
Warsaw 12
Boston 11
Changsha 11
Montreal 11
San Francisco 11
Shenyang 11
São Paulo 11
Falkenstein 10
Mexico City 10
Tokyo 9
Düsseldorf 8
Hebei 8
Frankfurt am Main 7
London 7
Norwalk 7
Pavia 7
Poplar 7
Atlanta 6
Brussels 6
Chicago 6
Denver 6
Orem 6
Rio de Janeiro 6
Santa Clara 6
The Dalles 6
Chennai 5
Guangzhou 5
Hangzhou 5
Johannesburg 5
Manchester 5
Mumbai 5
Phoenix 5
Piscataway 5
Quezon City 5
Tianjin 5
Vienna 5
Ann Arbor 4
Columbus 4
Curitiba 4
Elk Grove Village 4
Piracicaba 4
Rome 4
San Jose 4
Stockholm 4
Tallahassee 4
Turin 4
Washington 4
Austin 3
Buenos Aires 3
Chiba 3
Council Bluffs 3
Dhaka 3
Palermo 3
Paris 3
Querétaro 3
Querétaro City 3
Shijiazhuang 3
Tashkent 3
Vila Nova de Gaia 3
Xi'an 3
Amsterdam 2
Aracruz 2
Ashgabat 2
Asunción 2
Baku 2
Belo Horizonte 2
Bismarck 2
Bologna 2
Totale 1.996
Salva come PNG Salva come JPEG
Nome #
Addressing Vulvovaginal Atrophy (VVA)/Genitourinary Syndrome of Menopause (GSM) for Healthy Aging in Women 105
Barbed suture in minimally invasive hysterectomy: a systematic review and meta-analysis 87
Sexuality in premature ovarian insufficiency 86
Effectiveness of aromatase inhibitors in the treatment of advanced endometrial adenocarcinoma 82
Robotic single site hysterectomy with bilateral salpingo-oophorectomy in female to male transsexualism. 79
Single-site Versus Multiport Robotic Hysterectomy in Benign Gynecologic Diseases: A Retrospective Evaluation of Surgical Outcomes and Cost Analysis 79
Neoadjuvant Chemotherapy Followed by Radical Surgery versus Concurrent Chemo-Radiotherapy in the Treatment of Locally Advanced Cervical Cancer: A Multicenter Retrospective Analysis 78
Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer 77
Robotic single-site technique allows pelvic lymphadenectomy in surgical staging of endometrial cancer 77
Robotic single-site hysterectomy: Two institutions' preliminary experience 76
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? 76
Robotic single-site surgery in management of obese patients with early-stage endometrial cancer 75
Bilateral ovarian malakoplakia: Case report and review of the literature with clinical and diagnostic considerations 74
Oxaliplatin for the treatment of ovarian cancer 73
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 72
The role of hormone therapy in urogenital health after menopause 71
Current opinion on bevacizumab on endometrial cancer treatment 70
Palliative treatment of endometrial cancer: what is the role of anastrozole in elderly women? 69
Veliparib for the treatment of ovarian cancer 68
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 63
Hyaluronic Acid: A Valid Therapeutic Option for Early Management of Genitourinary Syndrome of Menopause in Cancer Survivors? 60
Robotic single-site surgery for female-to-male transsexuals: preliminary experience. 59
Different local estrogen therapies for a tailored approach to GSM 56
Role of dacarbazine in the treatment of recurrent mullerian adenosarcoma with sarcomatous overgrowth: Our experience 56
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 54
The role of fulvestrant in endometrial cancer 54
Pathologic Findings at Risk Reducing Surgery in BRCA and Non-BRCA Mutation Carriers: A Single-Center Experience 53
Exploring differences in psychological aspects during pregnancy between cancer survivors and women without a history of cancer 52
Maintenance pharmacological therapy of recurrent vulvovaginal candidiasis. A Bayesian network meta-analysis of randomized studies 51
Four pathogenic variants co-occurring in a MINAS early-onset breast cancer 47
Menopause and endometriosis 46
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy 43
Insights into the vulvar component of the genitourinary syndrome of menopause (GSM) 42
Oral contraception use in BRCA gene mutation carriers: information for counselling in routine clinical practice 42
Pharmacokinetic evaluation of fezolinetant for the treatment of vasomotor symptoms caused by menopause 42
Impact of totally implanted venous access port placement on body image in women with breast cancer 41
Tubal histopathological abnormalities in BRCA1/2 mutation carriers undergoing prophylactic salpingo-oophorectomy: a case-control study 41
Long-term risk of malignancy in the neovagina created using colon graft in vaginal agenesis-A case report 40
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status 39
The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis 38
Intralesional hemorrhage in Krukenberg tumor: A case report and review of the literature 38
Intralymphatic Histiocytosis Associated with Tubo-ovarian High-grade Serous Carcinoma: Case Report and Review of the Literature 37
Real world data of niraparib in platinum sensitive relapsed ovarian cancer: A multicenter experience of the MITO group 37
Multiple human papillomavirus infection and high-grade cervical squamous intraepithelial lesions among women with human immunodeficiency virus: a systematic review and a meta-analysis 36
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 35
Psychological Well-Being, Prenatal Attachment, and Quality of Early Mother-Infant Interaction: A Pilot Study With a Sample of Mothers With or Without Cancer History 35
Surveillance alone in stage i malignant ovarian germ cell tumors: A MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 34
RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers 31
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 30
Managing Menopausal Symptoms in Young Women With Breast Cancer: When Medicine Is Not All. The Take Care Project 27
Motherhood during or after breast cancer diagnosis: A qualitative study 27
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 26
MITO39: Efficacy and Tolerability of Pegylated Liposomal Doxorubicin (PLD)–Trabectedin in the Treatment of Relapsed Ovarian Cancer after Maintenance Therapy with PARP Inhibitors—A Multicenter Italian Trial in Ovarian Cancer Observational Case-Control Study 25
The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): The MITO-9 study 24
Term pregnancy and mode of delivery 24
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 22
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 22
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 22
Ovarian cancer onset across different BRCA mutation types: A view to a more tailored approach for BRCA mutated patients 22
Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs 18
A profile of safety and efficacy of fezolinetant for the treatment of menopausal vasomotor symptoms 17
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 14
null 5
Totale 3.101
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.973
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 1 2 13 10 7 1 1
2021/202294 0 0 6 0 1 5 1 6 7 1 14 53
2022/2023361 28 40 1 17 26 35 0 22 166 3 17 6
2023/2024285 7 38 7 13 10 60 7 16 2 9 16 100
2024/2025965 34 63 12 12 7 78 40 72 252 61 110 224
2025/20261.152 202 160 185 228 305 72 0 0 0 0 0 0
Totale 3.101